Market Overview - The chemical products sector experienced a decline of 0.57% on the trading day, with Boyuan Co., Ltd. leading the losses [1] - The Shanghai Composite Index closed at 3986.9, down 0.73%, while the Shenzhen Component Index closed at 13532.13, down 1.16% [1] Stock Performance - Notable gainers in the chemical products sector included: - Hangzhou Oxygen Plant Co., Ltd. (002430) with a closing price of 29.52, up 9.99% and a trading volume of 494,700 shares, totaling 1.43 billion yuan [1] - Pioneer New Materials (300163) closed at 4.93, up 6.94% with a trading volume of 1,542,200 shares, totaling 759 million yuan [1] - Jinrongzi (002407) closed at 26.50, up 6.26% with a trading volume of 2,445,100 shares, totaling 6.408 billion yuan [1] - Major decliners included: - Boyuan Co., Ltd. (301617) closed at 94.00, down 7.66% with a trading volume of 78,600 shares, totaling 763 million yuan [2] - Jinhua New Materials (920015) closed at 58.33, down 7.29% with a trading volume of 132,100 shares, totaling 810 million yuan [2] - Poly United (002037) closed at 10.10, down 6.13% with a trading volume of 247,400 shares, totaling 254 million yuan [2] Capital Flow - The chemical products sector saw a net outflow of 933 million yuan from institutional investors, while retail investors contributed a net inflow of 665 million yuan [2] - The capital flow for specific stocks indicated: - Hangzhou Oxygen Plant Co., Ltd. had a net inflow of 1.52 billion yuan from institutional investors, while retail investors had a net outflow of 948.96 million yuan [3] - Yongtai Technology (002326) experienced a net inflow of 1.25 billion yuan from institutional investors, with a net outflow of 2.22 billion yuan from retail investors [3] - Yahua Group (002497) had a net inflow of 1.08 billion yuan from institutional investors, while retail investors saw a net outflow of 657.87 million yuan [3]

Company Performance - Poly United (SZ 002037) reported third-quarter results on October 30, with revenue approximately 4.604 billion yuan, an increase of 9.17% year-on-year [1] - The net profit attributable to shareholders was a loss of approximately 99.24 million yuan [1] - Basic earnings per share showed a loss of 0.2051 yuan [1]

证券代码：002037 证券简称：保利联合 公告编号：2025-46 保利联合化工控股集团股份有限公司 关于召开 2025 年第二次临时股东大会的通知 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重 大遗漏。 一、召开会议的基本情况 1、股东会届次：2025 年第二次临时股东大会 2、股东会的召集人：董事会 3、本次会议的召集、召开符合《中华人民共和国公司法》《深圳证券交易所股票上市规则》《深 圳证券交易所上市公司自律监管指引第 1 号——主板上市公司规范运作》等法律、行政法规、部门规章、 规范性文件及《公司章程》的有关规定。 4、会议时间： （1）现场会议时间：2025 年 11 月 18 日 09:30 （2）网络投票时间：通过深圳证券交易所系统进行网络投票的具体时间为 2025 年 11 月 18 日 9:15-9:25，9:30-11:30，13:00-15:00；通过深圳证券交易所互联网投票系统投票的具体时间为 2025 年 11 月 18 日 9:15 至 15:00 的任意时间。 5、会议的召开方式：现场表决与网络投票相结合。 6、会议的股权登记日：202 ...

经审核，监事会认为董事会编制和审议公司 2025 年第三季度报告 的程序符合法律、行政法规及中国证监会的规定，报告内容真实、准 确、完整地反映了公司的实际情况，不存在任何虚假记载、误导性陈 述或者重大遗漏。 证券代码：002037 证券简称：保利联合 公告编号：2025-47 保利联合化工控股集团股份有限公司 第七届监事会第十六次会议决议公告 本公司及监事会全体成员保证信息披露内容的真实、准确和完整，没有虚假记载、误导 性陈述或重大遗漏。 保利联合化工控股集团股份有限公司（以下简称"公司"）第七届 监事会第十六次会议通知于 2025 年 10 月 15 日通过电子邮件发出， 会议于 2025 年 10 月 28 日以通讯表决方式召开。本次会议应参加表决 监事 3 名，实际参加表决监事 3 名。本次会议的召集、召开符合《公 司法》和《公司章程》的规定。根据《深圳证券交易所股票上市规则》 的有关规定，现将会议审议通过的议案公告如下： 一、议案审议情况 1.审议通过《关于公司 2025 年第三季度报告的议案》 表决结果：同意 3 票，反对 0 票，弃权 0 票。 具体内容详见同日刊载于《中国证券报》《证券时报》及巨 ...

证券代码：002037 证券简称：保利联合 公告编号：2025-44 保利联合化工控股集团股份有限公司 具体内容请详见同日刊载于《中国证券报》《证券时报》及在巨 潮资讯网（www.cninfo.com.cn）上的《2025 年第三季度报告》。 本议案已经董事会风控与审计委员会 2025 年第四次工作会审议 通过。 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假记载、误导 性陈述或重大遗漏。 保利联合化工控股集团股份有限公司（以下简称公司）第七届董 事会第十九次会议通知于 2025 年 10 月 15 日通过电子邮件发出，会议 于 2025 年 10 月 28 日以通讯表决方式召开。本次会议应参加表决董事 7 名，实际参加表决董事 7 名。本次会议的召集和召开符合《中华人 民共和国公司法》和《公司章程》的规定。根据《深圳证券交易所股 票上市规则》的有关规定，现将会议审议情况公告如下： 一、议案审议情况 1.审议通过《关于公司 2025 年第三季度报告的议案》 表决结果：同意 7 票，反对 0 票，弃权 0 票。 2.审议通过《关于召开公司 2025 年第二次临时股东大会的议案》 表决结果：同 ...

Financial Performance - The company's revenue for the third quarter was ¥1,421,906,791.17, a decrease of 13.91% compared to the same period last year[5] - The net profit attributable to shareholders was -¥39,257,155.26, representing a decline of 550.22% year-on-year[5] - The net profit attributable to shareholders after deducting non-recurring gains and losses was -¥38,983,502.12, down 282.74% from the previous year[5] - The basic and diluted earnings per share were both -¥0.0811, a decrease of 548.80% compared to the same period last year[5] - The net profit for the current period was a loss of ¥115,578,876.68, compared to a loss of ¥80,258,470.64 in the previous period, reflecting a deterioration in performance[20] - The basic and diluted earnings per share for the current period were both -0.2051, compared to -0.1200 in the previous period, indicating a decline in profitability per share[20] Assets and Liabilities - The total assets at the end of the reporting period were ¥16,855,215,152.09, a decrease of 1.15% from the end of the previous year[5] - Total current assets decreased from 9,727,565,901.94 CNY to 9,506,333,737.40 CNY, a decline of approximately 2.27%[16] - Cash and cash equivalents decreased from 1,555,038,627.75 CNY to 1,304,396,105.94 CNY, a reduction of about 16.14%[16] - The total liabilities decreased to ¥14,047,487,305.51 from ¥14,199,062,510.36, indicating a reduction in financial obligations[18] - Non-current liabilities increased significantly to ¥3,881,878,384.61, up from ¥2,876,656,464.35, showing a shift in the company's debt structure[18] - The total assets decreased to ¥16,855,215,152.09 from ¥17,051,184,434.32, indicating a contraction in the asset base[18] - The total equity attributable to the parent company decreased to ¥1,877,298,998.99 from ¥1,928,037,170.02, reflecting a decline in shareholder value[18] Cash Flow - The net cash flow from operating activities decreased by ¥59,300,543.25, an increase of 66.25% year-on-year[9] - The net cash flow from investing activities increased by ¥66,970,000, a growth of 38.32% compared to the previous year[9] - The net cash flow from financing activities decreased by ¥33,429,000, a decline of 95.92% year-on-year[9] - Operating cash flow for the current period was -59,300,543.25 CNY, an improvement from -175,728,800.71 CNY in the previous period[21] - Total cash inflow from operating activities increased to 4,224,099,023.99 CNY, up from 3,755,201,335.64 CNY year-over-year[21] - Cash outflow from operating activities rose to 4,283,399,567.24 CNY, compared to 3,930,930,136.35 CNY in the prior period[21] - Net cash flow from investing activities was -107,801,518.20 CNY, an improvement from -174,768,837.13 CNY in the previous year[21] - Cash inflow from financing activities totaled 3,358,949,919.05 CNY, down from 4,046,119,778.98 CNY year-over-year[22] - Net cash flow from financing activities was 14,220,156.41 CNY, a decrease from 348,506,777.79 CNY in the previous period[22] - The ending cash and cash equivalents balance was 1,041,790,771.60 CNY, compared to 910,447,652.30 CNY at the end of the previous period[22] - Cash inflow from the issuance of new investments was 5,784,000.00 CNY, significantly higher than 220,000.00 CNY in the prior period[22] - Cash outflow for the purchase of fixed assets was 135,579,126.41 CNY, down from 178,551,291.59 CNY year-over-year[21] Shareholder Information - The largest shareholder, Poly Jiulian Holdings Group, holds 29.65% of shares, totaling 143,478,060 shares[13] - Guizhou Baojiu Security Group is the second-largest shareholder with a 14.84% stake, amounting to 71,829,494 shares[13] - The total liabilities and equity structure remains stable with no significant changes reported in the shareholder financing activities[13] - There are no changes in the top 10 shareholders' participation in margin trading or securities lending activities[13] Operating Performance - Total operating revenue for the current period reached ¥4,604,349,087.89, an increase of 9.1% compared to ¥4,217,524,291.52 in the previous period[19] - Total operating costs increased to ¥4,704,462,144.92, up 9.3% from ¥4,302,072,208.72 in the previous period[19] - Research and development expenses rose to ¥117,629,159.91, an increase from ¥106,744,301.64, highlighting a commitment to innovation[19] Audit Information - The company did not undergo an audit for the third quarter financial report[23]

| 序号 | 股东 | 持股比例 | 持股变化 | | | --- | --- | --- | --- | --- | | 1 | 保利联合化工控股集团股份有限公司 | 85.5409% | 由 83.4077%变化至 | 85.5409% | 1 | 2 | 贵州省新型工业化发展股权投资基金 | 14.4591% | 无变化 | | --- | --- | --- | --- | | | 合伙企业（有限合伙） | | | 证券代码：002037 证券简称：保利联合 公告编号：2025-43 保利联合化工控股集团股份有限公司 关于诉讼事项的进展公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假记载、 误导性陈述或重大遗漏。 保利联合化工控股集团股份有限公司（以下简称保利联合或 公司）分别于 2024 年 12 月 7 日、2025 年 6 月 10 日在《中国证券 报》《证券时报》及巨潮资讯网（www.cninfo.com.cn）披露了《关 于诉讼、仲裁事项及相关进展的公告》（2024-50）、《关于诉讼 事项的进展公告》（2025-23）。上述已披露诉讼案件中"与罗勇、 张建军新增资本 ...

Market Overview - As of 14:00, the Shanghai Composite Index is at 3859.80 points, with an increase of 0.52% [1] - The total trading volume of A-shares today is 1,431.28 billion yuan [1] Technical Analysis - A total of 84 A-shares have seen their 5-day moving average cross below the 10-day moving average [1] - The stocks with the largest distance between their 5-day and 10-day moving averages include: - Yunnan Zhenye: 5-day MA is -2.45% below the 10-day MA [1] - Qiangli New Materials: 5-day MA is -2.22% below the 10-day MA [1] - Feirongda: 5-day MA is -2.14% below the 10-day MA [1] Individual Stock Performance - Yunnan Zhenye (002428): Today's change is -0.93%, with a 5-day MA of 27.71 yuan and a 10-day MA of 28.41 yuan [1] - Qiangli New Materials (300429): Today's change is +0.53%, with a 5-day MA of 13.95 yuan and a 10-day MA of 14.26 yuan [1] - Feirongda (300602): Today's change is +1.03%, with a 5-day MA of 33.00 yuan and a 10-day MA of 33.72 yuan [1] - Other notable stocks include: - Warner Pharmaceuticals (688799): Today's change is +0.43%, with a 5-day MA of 55.41 yuan [1] - Blue Ying Equipment (300293): Today's change is +0.34%, with a 5-day MA of 24.48 yuan [1] Additional Stock Data - The following stocks also show a downward trend in their 5-day moving averages compared to their 10-day moving averages: - Nanya New Materials (688519): -0.90% change, 5-day MA of 74.18 yuan [1] - Aerospace Morning Light (600501): -2.84% change, 5-day MA of 23.60 yuan [1] - Haichen Pharmaceutical (300584): +1.92% change, 5-day MA of 57.39 yuan [1]

Group 1 - The article highlights the top 20 stocks in the S&P China A-Share Dividend Opportunity Index, showcasing their daily and year-to-date performance along with dividend yields [1][2] - The stock with the highest daily increase is Xingri Co., Ltd. (002083.SZ) with a rise of 10.02%, while the highest year-to-date performer is Yiyi Co., Ltd. (001206.SZ) with a remarkable increase of 116.53% [1][2] - The overall dividend yield for the index is reported at 5.18%, with a historical price-to-earnings ratio of 10.64 times and an expected price-to-earnings ratio of 10.08 times [2] Group 2 - The article mentions the formation of a MACD golden cross signal, indicating a positive trend for certain stocks [3]

Core Viewpoint - The company has signed a strategic cooperation agreement with China Coal Energy Group, aiming to deepen collaboration in various business areas, particularly in mining blasting services [1]. Group 1: Strategic Cooperation - The actual controller of the company, China Poly Group, has recently signed a strategic cooperation agreement with China Coal Energy Group [1]. - The company has established a good cooperative relationship with China Coal in the field of mining blasting services and has undertaken related mining project construction [1]. - The signing of this agreement is seen as an opportunity to further deepen cooperation with China Coal in more business areas [1]. Group 2: Future Plans - The company will continue to focus on its main responsibilities and business areas while seeking to expand collaboration with China Coal [1]. - The company commits to fulfilling information disclosure obligations if there are any developments regarding the cooperation [1].